2023, Immunity and Immunization

Childhood vaccination coverage was falling across the globe even before Covid

STAT

JUNE 24, 2025

The study, which estimated childhood vaccination coverage between 1980 and 2023 in 204 countries and territories, found that the Covid-19 pandemic significantly intensified existing immunization challenges. Read the rest…

Vaccines

Vaccines Immunization Immunity

STAT+: Cancer therapy’s new ‘gold rush’: bispecific antibodies that hit key combination of targets

STAT

JANUARY 22, 2025

Immune checkpoint inhibitors, drugs that can help make the immune system recognize and destroy cancer more aggressively, are one of the most important medicines in cancer treatment today. Opdivo, from Bristol Myers Squibb, earned $10 billion in 2023.

Immunization

Immunization Immunity Compounding Drug Development

As its cancer vaccine moves through the clinic, Transgene sets sights on manufacturing

PharmaVoice

JULY 9, 2025

The company’s myvac platform creates individualized immunotherapies that stimulate and “educate” a patient’s immune system to destroy cancer tumors. We use AI to select the targets most likely to induce a strong immune response and incorporate these neoantigens into our viral vector.”

Vaccines

Vaccines Immunity Immunization Drug Development

Osivax publishes phase 2a results supporting dual flu vaccine approach

Pharma Times

JULY 10, 2025

The results, now published in Vaccines , show that the combination was well-tolerated with no serious adverse events, and generated strong immune responses. Robust NP-specific humoral and cell-mediated immune responses were observed in all participants given OVX836, whether alone or with Fluarix Tetra.

Vaccines

Vaccines Immunization Immunity

V116 Well-Tolerated With Broad Immune Responses in Pneumococcal Vaccine-Naïve Older Adults

Pharmacy Times

AUGUST 12, 2025

The vaccine showed superior immune response for unique serotypes compared to PPSV23, with higher OPA titers. 1,6,7 Robust Immunogenicity Elicited From V116 Compared With PPSV23 Between January 2023 and May 2023, individuals who were vaccine-naïve were recruited across 8 health care centers in Japan.

Immunity

Immunity Immunization Vaccines Pharmacy Technician

FDA expands AVTOZMA IV approval to include cytokine release syndrome

Pharma Times

AUGUST 7, 2025

CRS is a potentially life-threatening condition triggered by excessive immune activation. Celltrion emphasised the significance of the milestone in advancing treatment options for immune-related conditions. It leads to a rapid release of cytokines into the bloodstream, causing inflammation and damage to healthy tissues.

Biosimilars

Biosimilars Immunity Immunization

SAEM Clinical Images Series: Not Your Average Eczema

ALiEM - Pharm Pearls

DECEMBER 20, 2024

He is up to date on childhood immunizations and is not prescribed any oral medications. Copyright Images and cases from the Society of Academic Emergency Medicine (SAEM) Clinical Images Exhibit at the 2023 SAEM Annual Meeting | Copyrighted by SAEM 2023 – all rights reserved. J Emerg Med. 2011 Feb;40(2):167-9. 2007.11.049.

Immunity

Immunity Immunization

The MEK effect on cancer — a slow and steady approach to drug resistance

PharmaVoice

JULY 8, 2025

You just want to slash it, rip it out or attack it like an enemy target,” said Benjamin Zeskind, co-founder, CEO and president of Immuneering Corporation. To overcome that hurdle, Immuneering is testing an approach that slows cancer down rather than rushing to destroy it.

Immunity

Immunity Immunization Chemotherapy Packaging

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmaTech

JUNE 10, 2025

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. ACIP plays a foundational role in shaping immunization policy in the US. Kennedy Jr.

Vaccines

Vaccines Insurance Coverage and Processing Dosage Drug Development

Vyvgart Hytrulo gains first APAC approval in China, redefining CIDP care: GlobalData

Express Pharma

NOVEMBER 21, 2024

Additionally, it is approved in the EU for gMG and in Japan for gMG and primary immune thrombocytopenia (ITP) under brand names Vyvgart and Vyvdura. per cent from 56,009 in 2023 to 56,163 in 2027. The NRDL inclusion secured for gMG lowers the barrier for adoption in CIDP by facilitating reimbursement despite the drug’s high cost.

Immunity

Immunity Immunization

With scrapped mRNA funding, a vaccine maker finds a silver lining

PharmaVoice

AUGUST 14, 2025

Experts, however, pointed to the unprecedented speed with which mRNA vaccines were developed and distributed in response to the COVID-19 pandemic that would not have been possible using traditional immunization methods. Fellow COVID vaccinemaker Vaxart has also faced similar orders to stop working on its oral immunization not based on mRNA.

Vaccines

Vaccines Immunity Immunization Drug Pricing

Govt provides updates on measures to encourage domestic manufacturing

Express Pharma

DECEMBER 9, 2024

15,000 crores and a production tenure from FY 2022- 2023 to FY 2027-28, provides financial incentives to 55 selected applicants for manufacturing of identified products under three categories for six years. The scheme provides financial incentives for the manufacturing of notified products. are manufactured.

Immunity

Immunity Immunization

From Pharmacy Counters to Classrooms: Building Confidence in Back-to-School Vaccinations

Pharmacy Times

AUGUST 6, 2025

Parental vaccine hesitancy, fueled by misinformation and logistical barriers, contributes to lower immunization rates and increased exemption rates. Collaborative programs between public health departments, schools, and pharmacies aim to streamline vaccine access and improve immunization coverage.

Vaccines

Vaccines Pharmacy Technician Immunity Immunization

Flu Vaccines Are a Go

Pharmacy Times

JULY 16, 2025

That was the question on the minds of a lot of health care professionals, public policy leaders, public health officials, and select politicians going into the first meeting of the new Advisory Committee on Immunization Practices (ACIP) in June 2025. Editor's Footnote In May 2025, Secretary Robert F. Kennedy Jr.

Vaccines

Vaccines Insurance Coverage and Processing Pharmacy Technician Community Pharmacies

RSV Vaccine Uptake Remains Low Among US Adults Aged 60 Years and Older

Pharmacy Times

AUGUST 13, 2025

Following the availability of RSV vaccines in 2023, researchers aimed to evaluate the uptake from August 2023 to February 2025 among adults aged 60 years and older, using IQVIA's open-source pharmacy (LRx) and medical (Dx) claims data.

Vaccines

Vaccines Pharmacy Technician Immunity Immunization

Overcoming challenges in biosimilar analytical characterization

Drug Patent Watch

DECEMBER 9, 2024

Additionally, the immunogenicity of biosimilars, which is the ability of the drug to trigger an immune response, can be highly variable and impact the safety and efficacy of the drug. 2023, June 13). link] Kurki, P., 2021, November 2). Interchangeability of Biosimilars: Overcoming the Final Hurdles. link] Algorics. link] Source

Biosimilars

Biosimilars Immunity Immunization

Kantar study maps India’s health and wellness search trends for 2024

Express Pharma

AUGUST 12, 2025

The report covers 15 categories including Nutrients and Supplements, Skin Health, Physical Fitness, Weight Management, Cognitive and Mental Health, Women’s Health, Gut Health, Alternative Medicine, Sleep, Immune Health, Hydration, Lifestyle Choices, Advanced Medicine, Detoxification, and Longevity. million, up 14 per cent from 2023.

Immunity

Immunity Immunization

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Pharmacy Times

JUNE 20, 2025

Prior to October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a PCV only for all adults aged 65 years and older, including those aged 19 to 64 years with risk conditions for pneumococcal disease. Kobayashi M, Leidner AJ, Gierke R, et al. MMWR Morb Wkly Rep. 2025;74:1-8. doi:10.15585/mmwr.mm7401a1 3.

Vaccines

Vaccines Pharmacy Technician Immunity Immunization

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Pharmacy Times

JUNE 24, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Childhood vaccination coverage was falling across the globe even before Covid

STAT+: Cancer therapy’s new ‘gold rush’: bispecific antibodies that hit key combination of targets

Trending Sources

As its cancer vaccine moves through the clinic, Transgene sets sights on manufacturing

Osivax publishes phase 2a results supporting dual flu vaccine approach

V116 Well-Tolerated With Broad Immune Responses in Pneumococcal Vaccine-Naïve Older Adults

FDA expands AVTOZMA IV approval to include cytokine release syndrome

SAEM Clinical Images Series: Not Your Average Eczema

The MEK effect on cancer — a slow and steady approach to drug resistance

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

Vyvgart Hytrulo gains first APAC approval in China, redefining CIDP care: GlobalData

With scrapped mRNA funding, a vaccine maker finds a silver lining

Govt provides updates on measures to encourage domestic manufacturing

From Pharmacy Counters to Classrooms: Building Confidence in Back-to-School Vaccinations

Flu Vaccines Are a Go

RSV Vaccine Uptake Remains Low Among US Adults Aged 60 Years and Older

Overcoming challenges in biosimilar analytical characterization

Kantar study maps India’s health and wellness search trends for 2024

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Op-Ed: States Are Leading the Way on PBM Reform. Here’s How.

Expert Q&A: Empowering Independent Pharmacies Through the One Voice Initiative

Lipid-Lowering Effects Discovered in FDA-Approved Drugs Using Machine Learning

Inside the Synergy Between HOPA and OPC’s Evolving Educational Impact

Pharmacists Bridge the Gaps in Care Transitions

FDA Moving to Nonanimal Testing Methodologies in Preclinical Research

FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks

The Changing Landscape of Pharmacy Accessibility

Antidiabetic Medication Combinations Have Varying Effects on Diabetic Kidney Disease Progression

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Pharmacies Need Strategies to Improve Health Care Access

Carefully Monitor Direct Oral Anticoagulant Medications

Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment

COVID-19 Pandemic Reduced Gaps in Pneumococcal Vaccination in Medicare Enrollees, But Lowered Overall Uptake

Continuous Subcutaneous Lenalidomide Shows Promise in Reducing Toxicity in R/R Multiple Myeloma

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

Zongertinib Approved by FDA for Patients With Nonsquamous NSCLC With HER2 TKD Mutations

You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment

The Lifesaving Role of Continuous Glucose Monitors and Wearable Devices

Beyond Dispensing: How Pharmacists and Technicians Can Expand Services to Meet Patient Needs

A Few Key Points Can Guide SGLT2 Inhibitor Management

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Stay Connected